|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
94,670,000 |
Market
Cap: |
90.88(M) |
Last
Volume: |
940,193 |
Avg
Vol: |
714,677 |
52
Week Range: |
$0.754 - $7.66 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Assertio Therapeutics is a pharmaceutical company. Co.'s primary marketed products include: INDOCIN® (indomethacin) Suppositories and INDOCIN® (indomethacin) Oral Suspension, which is a suppository form and oral solution of indomethacin, a nonsteroidal anti-inflammatory drug (NSAID), approved for moderate to severe rheumatoid arthritis, ankylosing spondylitis and osteoarthritis; CAMBIA® (diclofenac potassium for oral solution), which is a prescription NSAID indicated for the acute treatment of migraine attacks in adults; and Otrexup® (methotrexate) injection, used to treat adults with severe, active rheumatoid arthritis, and children with active polyarticular juvenile idiopathic arthritis.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Cameron Tammy |
VP, Finance |
|
2011-06-14 |
4 |
S |
$8.20 |
$245,562 |
D/D |
(29,913) |
3,960 |
|
- |
|
Cameron Tammy |
VP, Finance |
|
2011-06-14 |
4 |
OE |
$1.83 |
$70,396 |
D/D |
23,334 |
21,453 |
|
- |
|
Zenoff David B |
Director |
|
2011-05-16 |
4 |
B |
$8.02 |
$18,446 |
I/I |
2,300 |
19,596 |
2.1 |
- |
|
Staple Peter D |
Director |
|
2011-05-13 |
4 |
B |
$7.97 |
$19,925 |
I/I |
2,500 |
15,000 |
2.1 |
- |
|
Burrill Steven |
Director |
|
2011-05-13 |
4 |
S |
$8.09 |
$560,025 |
D/D |
(69,250) |
40,000 |
|
- |
|
Burrill Steven |
Director |
|
2011-05-13 |
4 |
OE |
$1.49 |
$225,950 |
D/D |
69,250 |
109,250 |
|
- |
|
Staple Peter D |
Director |
|
2011-05-12 |
4 |
B |
$8.30 |
$20,750 |
I/I |
2,500 |
12,500 |
2.1 |
- |
|
Cameron Tammy |
VP, Finance |
|
2011-05-12 |
4 |
S |
$8.26 |
$155,367 |
D/D |
(18,821) |
10,054 |
|
- |
|
Cameron Tammy |
VP, Finance |
|
2011-05-12 |
4 |
OE |
$1.83 |
$34,442 |
D/D |
18,821 |
28,875 |
|
- |
|
Burrill Steven |
Director |
|
2011-05-12 |
4 |
S |
$8.25 |
$717,750 |
D/D |
(87,000) |
40,000 |
|
- |
|
Burrill Steven |
Director |
|
2011-05-12 |
4 |
OE |
$1.95 |
$313,250 |
D/D |
62,000 |
127,000 |
|
- |
|
Cameron Tammy |
VP, Finance |
|
2011-05-11 |
4 |
S |
$8.36 |
$406,630 |
D/D |
(47,742) |
10,054 |
|
- |
|
Cameron Tammy |
VP, Finance |
|
2011-05-11 |
4 |
OE |
$1.83 |
$91,868 |
D/D |
47,742 |
27,796 |
|
- |
|
Burrill Steven |
Director |
|
2011-04-04 |
4 |
OE |
$3.40 |
$34,000 |
D/D |
10,000 |
65,000 |
|
- |
|
Stern Julian N |
Director |
|
2011-03-03 |
4 |
OE |
$3.40 |
$68,000 |
D/D |
20,000 |
183,333 |
|
- |
|
Stern Julian N |
Director |
|
2009-10-21 |
4 |
OE |
$3.27 |
$98,250 |
D/D |
30,000 |
163,333 |
|
- |
|
Gosling Matthew M |
VP, General Counsel |
|
2009-08-11 |
4 |
S |
$3.64 |
$101,712 |
D/D |
(27,724) |
0 |
|
- |
|
Gosling Matthew M |
VP, General Counsel |
|
2009-08-11 |
4 |
OE |
$1.98 |
$29,700 |
D/D |
15,000 |
2,500 |
|
- |
|
Burrill Steven |
Director |
|
2009-07-10 |
4 |
OE |
$2.88 |
$43,125 |
D/D |
15,000 |
55,000 |
|
- |
|
Staple Peter D |
Director |
|
2009-06-15 |
4 |
B |
$2.67 |
$13,402 |
I/I |
5,000 |
10,000 |
2.1 |
- |
|
Staple Peter D |
Director |
|
2009-03-11 |
4 |
B |
$1.98 |
$10,021 |
I/I |
5,000 |
5,000 |
2.1 |
- |
|
Pelzel Carl A |
President and CEO |
|
2009-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
44,808 |
|
- |
|
Zenoff David B |
Director |
|
2008-12-11 |
4 |
B |
$1.55 |
$9,999 |
I/I |
6,451 |
17,296 |
2.1 |
- |
|
Dawes Karen A |
Director |
|
2008-12-01 |
4 |
B |
$1.44 |
$7,200 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
Burrill Steven |
Director |
|
2008-11-26 |
4 |
B |
$1.45 |
$61,444 |
D/D |
40,000 |
40,000 |
2.39 |
- |
|
246 Records found
|
|
Page 9 of 10 |
|
|